Oxford and Serum Institute Partner on New Malaria Vaccine
Oxford University and Serum Institute of India have partnered to develop R78C, a new malaria vaccine that targets multiple stages of the parasite. Serum will manufacture doses at scale, potentially accelerating access in high-burden regions like sub-Saharan Africa.